We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tea Drinking Significantly Reduces Risk of Stroke

By LabMedica International staff writers
Posted on 04 Mar 2009
A recently published study reviewed the experimental evidence linking tea drinking and stroke and concluded that drinking at least three cups of tea a day significantly reduces stroke risk.

Investigators from the University of California, Los Angeles (UCLA; USA) searched the Internet for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. More...
Data from nine studies involving 4,378 strokes among 194,965 individuals were pooled.

Results published in the February 19, 2009, online edition of Stroke, a Journal of the American Heart Association, revealed that regardless of their country of origin, individuals consuming at least three cups of tea per day had a 21% lower risk of stroke than those consuming less than one cup per day. The tea could be black or green as long it was from the classical tea plant Camellia sinensis and not an herbal tea.

So far, researchers have failed to identify the compounds in tea responsible for the stroke-reducing effect. Speculation points to the antioxidant epigallocatechin gallate (EGCG) or the amino acid theanine. Theanine is especially interesting, as it is related to glutamine and can cross the blood-brain barrier. Since it can enter the brain, theanine has psychoactive properties. Theanine has been shown to reduce mental and physical stress and produce feelings of relaxation.

"What we saw was that there was a consistency of effect of appreciable magnitude,” said first author Dr. Lenore Arab, professor of biological chemistry at the University of California, Los Angeles. "By drinking three cups of tea a day, the risk of a stroke was reduced by 21%. It did not matter if it was green or black tea. That is why these findings are so exciting. If we can find a way to prevent the stroke, or prevent the damage, that is simple and not toxic, that would be a great advance. We do know that theanine is nearly 100% absorbed. It gets across the blood-brain barrier and it looks a lot like a molecule that is very similar to glutamate, and glutamate release is associated with stroke. It could be that theanine and glutamate compete for the glutamate receptor in the brain.”

Related Links:
University of California, Los Angeles




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.